By restoring the physiological process of KCs proliferation and differentiation and reducing the expression of vascular endothelial growth factor A (VEGF-A), IL-38 remarkably alleviated the severity of psoriasis like phenotype induced by imiquimod (IMQ) (Mercurio et al., 2018). The gene discussed is VEGFA; the disease is psoriasis.